The association between common C677T mutation in methylenetetrahydrofolate reductase gene and the risk of venous thrombosis in an Iranian population

Laboratory Medicine

Volumn 39, Issue 2, 2008, Pages 97-100

  Soltanpour, Mohammad Soleyman ^a   Soheili, Zahra ^b   Pourfathollah, Ali Akbar ^a   Samiei, Shahram ^c   Meshkani, Reza ^d   Deyhim, Mohammad Reza ^c   Safa, Majid ^a,e   Ataei, Zahra ^c  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^c IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 62749191484     PISSN: 00075027     EISSN: None     Source Type: Journal    
DOI: 10.1309/BHB986MDHMGQP9VG     Document Type: Article

References (41)

1. White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107:4-8.
2. Anderson FA, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107:9-16.
3. Fermo I, D'Angelo CV, Paroni R, et al. A. Prevalence of moderate hyperhomocysteinemia in patients with early onset venous and arterial disease. Ann Intern Med. 1995;123:747-753.
4. Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med. 1991;324:1149-1155.
5. Ray JG. Meta-Analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. Arch Intern Med. 1998; 158:2101-2116.
6. Jacques PF, Bostom AG, Williams RR, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 1996;93:7-9.
7. De Stefano V, Chiusolo P, Paciaroni K, et al. Prevalence of the 677C to T mutation in the methylenetetrahydrofolate reductase gene in Italian patients with venous thrombotic disease. Thromb Haemost. 1998;79:686-687.
8. Tosetto A, Missiaglia E, Frezzato M, et al. The VITA project: C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene and risk of venous thromboembolism. Br J Haematol. 1997;97:804-806.
9. Shmeleva VM, Kapustin SI, Papayan LP, et al. Prevalence of hyperhomocysteinemia and the MTHFR C677T polymorphism in patients with arterial and venous thrombosis from North Western Russia. Thromb Res. 2003;111:351-356.
10. Lahiri DK, Nurnberger JI. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Research. 1991;19:5444.
11. Refsum H, Ueland PM, Nygard O, et al. Homocysteine and cardiovascular disease. Annu Rev Med. 1998;49:31-62.
12. Gemmati D, Previati M, Serino ML, et al. Low folate levels and thermolabile methylenetetrahydrofolate reductase as primary determinant of mild hyperhomocysteinemia in normal and thrombembolic subjects. Arterioscler Thromb Vas Biol. 1999;19:1761-1767.
13. Chambers JC, Ireland H, Thompson E, et al. Methylenetetrahydrofolate reductase 677 C→T mutation and coronary heart disease risk in UK Indian Asians. Arterioscler Thromb Vasc Biol. 2000;20:2448-2452.
14. Engbersen AM, Franken DG, Boers GH, et al. Thermolabile 5, 10-methylenetetrahydrofolate reductase as a cause for mild hyperhomocysteinemia. Am J Hum Genet. 1995;56:142-150.
15. Harmon DL, Woodside JV, Yarnell JWG, et al. The common 'thermolabile' variant of methylenetetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. Q J Med. 1996;89:571-577.
16. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111-113.
17. Pathare A, Al Kindi S, Al Belushi T, et al. Heterozygous methylene tetrahydrofolate reductase mutation with mild hyperhomocysteinemia associated with deep vein thrombosis. Haematologia. 2002;32:551-556.
18. Berrut G, Ghali A, Quere I, et al. A common mutation C677T in the 5, 10-methyltetrahydrofolate reductase gene is associated to idiopathic deep venous thrombosis. Rev Med Interne. 2003;24:569-576.
19. Seinost G, Renner W, Brodmann M, et al. C677T mutation in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombotic disease in Austrian patients. Throm Res. 2000;100:405-407.
20. Zalavras CHG, Giotopoulou S, Dokou E, et al. Lack of association between the C677T mutation in the 5, 10-methylenetetrahydrofolate reductase gene and venous thromboembolism in Northwestern Greece. Inter Angio. 2002;21:268-271.
21. Balta G, Gurgey A. Methylenetetrahydrofolate reductase (MTHFR) C677 T mutation in Turkish patients with thrombosis. Turk J Pediatr. 1999;41:197-199.
22. Quere I, Chasse JF, Dupuy E, et al. Homocysteine, 5, 10-methylenetetrahydrofolate reductase and deep venous thrombosis. Survey of 120 patients in internal medicine. Rev Med Interne. 1998;19:29-33.
23. Girelli D, Friso S, Trabetti E, et al. Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: Evidence for an important genetic-environmental interaction. Blood. 1998;91:4158-4163.
24. Huh HJ, Chi HS, Shim EH, et al. Gene-nutrition interactions in coronary artery disease: Correlation between the MTHFR C677T polymorphism and folate and homocysteine status in a Korean population. Thromb Res. 2006;117:501-506.
25. Arruda VR, Von Zuben PM, Chiaparini LC, et al. The mutation Ala 677 Val in the methylenetetrahydrofolate reductase gene: A risk factor for arterial disease and venous thrombosis. Thromb Haemost. 1997;77:818-821.
26. Hsu LA, Ko YL, Wang SM, et al. The C677T mutation of the methylenetetrahydrofolate reductase gene is not associated with the risk of coronary artery disease or venous thrombosis among Chinese in Taiwan. Hum Hered. 2001;51:41-45.
27. Bezemer ID, Doggen CJ, Vos HL, et al. No association between the common MTHFR 677 → T polymorphism and venous thrombosis. Arch Intern Med. 2007;167:497-501.
28. Couturaud F, Oger E, Abalain JH, et al. Methylenetetrahydrofolate reductase C677T genotype and venous thromboembolic disease. Respiration. 2000;67:657-661.
29. Gemmati D, Serino ML, Triveliato C, et al. C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients. Haematologica. 1999;84:824-828.
30. Zheng YZ, Tong J, Do XP, et al. Prevalence of methylenetetrahydrofolate reductase C677T and its association with arterial and venous thrombosis in the Chinese population. Br J Haematol. 2000;109:870-874.
31. Yebra M, Fernández-Miranda C, Prieto Rodríguez S, et al. Hyperhomocysteinemia and multiple arterial thrombosis in a young patient with mutation of methylentetrahydrofolate reductase C677T. Rev Clin Esp. 2004;204:607-608.
32. Franchis DE, Mancini R, D'Angelo FP, et al. Elevated total plasma homocysteine and 677→T mutation of the 5, 10 methylenetetrahydrofolate reductase gene in thrombotic vascular disease. Am J Hum Genet. 1996;59:262-264.
33. Sazci A, Ergul E, Kaya G, et al. Genotype and allele frequencies of the polymorphic methylenetetrahydrofolate reductase gene in Turkey. Cell Biochem Funct. 2005;23:51-54.
34. Hegele RA, Tully C, Young TK, et al. V677 mutation of methylenetetrahydrofolate reductases and cardiovascular disease in Canadian Inuit. Lancet. 1997;349:1221-1222.
35. Ubbink JB, Christianson A, Van Allen MJ, et al. Folate status, homocysteine metabolism, and methylene tetrahydrofolate reductase genotype in rural South African blacks with a history of pregnancy complicated by neural tube defects. Metabolism. 1999;48:269-274.
36. Franco RF, Araujo AG, Guerreiro JF, et al. Analysis of the 677 C→T mutation of the methylenetetrahydrofolate reductase gene in different ethnic groups. Thromb Haemost. 1998;79:119-121.
37. Jen-Shiou L, Ming-Ching S, Woei T, et al. The prevalence of C677T mutation in the methylenetetrahydrofolate reductase gene and its association with venous thrombophilia in Taiwanese Chinese. Throm Res. 2000;97:89-94.
38. Tsai AW, Cushman M, Tsai MY, et al. Serum homocysteine, thermolabile variant of methylene tetrahydrofolate reductase (MTHFR), and venous thromboembolism: Longitudinal investigation of thromboembolism (LITE). Am J Hematol. 2003;72:192-200.
39. Ridker PM, Hennekens CH, Selhub J, et al. Interrelation of hyperhomocysteinemia, factor V Leiden, and risk of future venous thromboembolism. Circulation. 1997;95:1777-1782.
40. Den Heijer M, Rosendaal F, Blom H, et al. Hyperhomocysteinemia and venous thrombosis: A metaanalysis. Thromb Haemost. 1998; 80:874-877.
41. Den Heijer M, Levington S, Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: A meta-analysis of published epidemiological studies. J Thromb Haemost. 2005;3:292-299.